(Q44135928)

English

A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells

scientific article published in September 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

phosphorylation

1 reference

based on heuristic

inferred from title

author name string

Ya-Li Zheng

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Bing-Sheng Li

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Niranjana D Amin

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Wayne Albers

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Harish C Pant

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

269

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

4427-4434

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Molecular cloning and chromosomal mapping of the mouse gene encoding cyclin-dependent kinase 5 regulatory subunit p35.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

Interaction of cyclin-dependent kinase 5 (Cdk5) and neuronal Cdk5 activator in bovine brain.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

A decade of CDK5.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

Cdk5 behind the wheel: a role in trafficking and transport?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

The crystal structure of cyclin A

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

Identification of functional domains in the neuronal Cdk5 activator protein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

Principles of CDK regulation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

Regulation of cyclin-dependent kinase 5 catalytic activity by phosphorylation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

Structure and regulation of the CDK5-p25(nck5a) complex

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

Tau in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p23) transfected cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

Cyclin-dependent Kinase 5 (Cdk5) Activation Domain of Neuronal Cdk5 Activator

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2002.03133.X

21 January 2018

Identifiers

10.1046/J.1432-1033.2002.03133.X

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44135928&oldid=2106980072"